A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies
NCT06698796
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
211
Enrollment
INDUSTRY
Sponsor class
Conditions
Dermatomyositis
Polymyositis
Interventions
DRUG:
Dazukibart
Sponsor
Pfizer